Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ceftriaxone (250mg) + Sulbactam (125mg)
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial + Water
Packaging
mono
Price
₹75/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fritcet S 375 Injection combines Ceftriaxone, a third-generation cephalosporin antibiotic, with Sulbactam, a beta-lactamase inhibitor. This dual action ensures potent antibacterial activity by not only inhibiting the synthesis of the bacterial cell wall but also preventing beta-lactamase enzymes from neutralizing the antibiotic. This makes the combination effective against a broad spectrum of gram-positive and gram-negative bacteria, including those resistant to other antibiotics.
Fritcet S 375 Injection is widely used to treat moderate to severe infections caused by susceptible microorganisms. These include respiratory infections, urinary tract infections, soft tissue infections, bacterial meningitis, sepsis, and intra-abdominal infections. It is particularly valuable in the treatment of infections caused by beta-lactamase-producing bacteria, which are often resistant to other antibiotics.
May include nausea, vomiting, rash, diarrhea, and local injection site reactions. Serious effects may involve allergic reactions or liver/kidney dysfunction.
For the treatment of moderate to severe bacterial infections, including respiratory, urinary tract, skin, and intra-abdominal infections.
Administer under medical supervision, especially in patients with penicillin or cephalosporin allergies.
Store at room temperature, away from moisture and sunlight. Keep out of reach of children.
Composition : Ceftriaxone (1000mg) + Sulbactam (500mg)
Composition : Ceftriaxone (125mg) Injection
Composition : Ceftriaxone (250mg)
Composition : Ceftriaxone (250mg) + Tazobactum (31.25mg)
Composition : Ceftriaxone (500mg)
Composition : Ceftriaxone (500mg) + Sulbactam (250mg)
Composition : Cefuroxime (1500mg)
Composition : Cefuroxime (1.5gm)
Composition : Cefuroxime (1500mg) + Sulbactam (750mg)
Composition : Clarithromycin (500mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ceftriaxone 250mg + Sulbactam 125mg Injection has strong demand in the hospital care, critical care, surgical, and anti-infective segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable antibiotic portfolios.
Medical distributors and agencies can benefit from consistent demand for moderate to severe bacterial infection management under medical supervision. Ceftriaxone is a third-generation cephalosporin antibiotic with broad-spectrum activity Sulbactam is a beta-lactamase inhibitor that helps enhance antibiotic effectiveness against resistant bacteria Commonly prescribed for respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and post-surgical infections Helps improve effectiveness against beta-lactamase producing organisms Frequently used in hospitals, ICUs, emergency departments, and surgical wards Widely prescribed by physicians, surgeons, intensivists, and infectious disease specialists This strengthens a comprehensive critical care and anti-infective injectable portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ceftriaxone 250mg + Sulbactam 125mg Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, institutional procurement opportunities, repeat orders, reliable supply chain support, and attractive margins in the injectable antibiotic segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.